Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 535.24M | 516.01M | 493.61M | 427.79M | 379.51M | 310.64M |
Gross Profit | 199.51M | 198.78M | 180.73M | 103.36M | 113.15M | 104.86M |
EBITDA | 72.85M | 71.53M | 58.61M | 14.06M | 26.66M | 46.52M |
Net Income | 60.60M | 55.95M | 46.63M | 7.81M | 19.02M | 32.66M |
Balance Sheet | ||||||
Total Assets | 383.97M | 362.38M | 285.68M | 197.76M | 197.48M | 183.86M |
Cash, Cash Equivalents and Short-Term Investments | 153.61M | 164.67M | 132.54M | 19.63M | 28.69M | 72.18M |
Total Debt | 12.59M | 435.00K | 1.22M | 48.00K | 76.00K | 25.06M |
Total Liabilities | 106.11M | 103.56M | 83.25M | 56.66M | 74.31M | 81.56M |
Stockholders Equity | 277.86M | 258.82M | 202.44M | 141.09M | 123.17M | 102.22M |
Cash Flow | ||||||
Free Cash Flow | 31.96M | 41.92M | 106.56M | -11.92M | -16.72M | 32.93M |
Operating Cash Flow | 33.37M | 42.90M | 107.16M | -10.94M | -16.17M | 33.32M |
Investing Cash Flow | -1.41M | -974.00K | -594.00K | -982.00K | -557.00K | -375.00K |
Financing Cash Flow | -309.00K | -8.30M | 6.29M | 3.03M | -26.80M | 2.05M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $4.21B | 22.61 | 40.81% | ― | 0.34% | 9.48% | |
76 Outperform | $2.09B | 36.53 | 24.86% | ― | 8.01% | 11.26% | |
74 Outperform | $3.53B | 12.43 | 23.07% | 4.25% | 13.22% | 11.37% | |
65 Neutral | $27.28B | 15.30 | -4.01% | 3.16% | 1.00% | 1.98% | |
54 Neutral | $227.12M | ― | -28.87% | ― | -6.83% | 19.09% | |
52 Neutral | $361.53M | ― | -85.68% | ― | 4.56% | 57.03% | |
39 Underperform | $53.33M | ― | -117.82% | ― | 22.04% | -21.72% |
On June 12, 2025, Vita Coco’s subsidiary, All Market Singapore PTE Ltd., amended its Manufacturing and Purchasing Agreement with Century Pacific Agricultural Ventures, Inc. The amendment extends the agreement to December 31, 2030, revises pricing and volume terms, and imposes sustainability obligations on Century Pacific, including adherence to ethical trade audits.
The most recent analyst rating on (COCO) stock is a Buy with a $38.00 price target. To see the full list of analyst forecasts on Vita Coco Company stock, see the COCO Stock Forecast page.
On June 3, 2025, The Vita Coco Company held its Annual Meeting of Stockholders, where 89% of the voting power was represented. During the meeting, Aishetu Fatima Dozie, Martin Roper, and John Zupo were elected as Class I directors, and the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for 2025 was ratified. Additionally, an advisory vote on executive compensation was approved.
The most recent analyst rating on (COCO) stock is a Hold with a $33.00 price target. To see the full list of analyst forecasts on Vita Coco Company stock, see the COCO Stock Forecast page.